Hantz Financial Services, Inc. Bristol Myers Squibb CO Transaction History

Hantz Financial Services, Inc.

  • $5.63 Billion
  • Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 4,349 shares of BMY stock, worth $253,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,349
Previous 4,455 2.38%
Holding current value
$253,242
Previous $185,000 21.62%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$39.66 - $51.75 $4,203 - $5,485
-106 Reduced 2.38%
4,349 $225,000
Q2 2024

Jul 30, 2024
BUY
$40.25 - $52.99 $179,313 - $236,070
4,455 New
4,455 $185,000
Q1 2024

Aug 06, 2024
SELL
$47.98 - $54.4 $7,388 - $8,377
-154 Reduced 5.24%
2,784 $151,000
Q4 2023

Aug 06, 2024
SELL
$48.48 - $57.85 $9,792 - $11,685
-202 Reduced 6.43%
2,938 $151,000
Q3 2023

Aug 06, 2024
SELL
$57.89 - $64.73 $5.54 Million - $6.2 Million
-95,774 Reduced 96.83%
3,140 $182,000
Q2 2023

Aug 06, 2024
BUY
$63.71 - $70.74 $42,239 - $46,900
663 Added 0.67%
98,914 $6.33 Million
Q1 2023

Aug 06, 2024
BUY
$65.71 - $74.53 $87,525 - $99,273
1,332 Added 1.37%
98,251 $6.81 Million
Q4 2022

Aug 06, 2024
BUY
$68.48 - $81.09 $224,545 - $265,894
3,279 Added 3.5%
96,919 $6.97 Million
Q3 2022

Aug 06, 2024
BUY
$0.13 - $76.84 $261 - $154,755
2,014 Added 2.2%
93,640 $6.66 Million
Q2 2022

Aug 06, 2024
BUY
$72.62 - $79.98 $265,498 - $292,406
3,656 Added 4.16%
91,626 $7.06 Million
Q1 2022

Aug 06, 2024
BUY
$61.48 - $73.72 $312,687 - $374,939
5,086 Added 6.14%
87,970 $6.42 Million
Q4 2021

Aug 06, 2024
BUY
$53.63 - $62.52 $190,815 - $222,446
3,558 Added 4.49%
82,884 $5.17 Million
Q3 2021

Aug 06, 2024
BUY
$59.17 - $69.31 $2.36 Million - $2.76 Million
39,829 Added 100.84%
79,326 $4.69 Million
Q2 2021

Aug 06, 2024
BUY
$61.91 - $67.42 $215,261 - $234,419
3,477 Added 9.65%
39,497 $2.64 Million
Q1 2021

Aug 06, 2024
BUY
$59.34 - $66.74 $1.87 Million - $2.11 Million
31,565 Added 708.53%
36,020 $2.27 Million
Q4 2020

Aug 06, 2024
BUY
$57.74 - $65.43 $10,162 - $11,515
176 Added 0.49%
35,743 $2.22 Million
Q3 2020

Aug 06, 2024
BUY
$57.43 - $63.64 $1.79 Million - $1.98 Million
31,112 Added 698.36%
35,567 $2.14 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email